Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AVEO Pharmaceuticals begins enrollment in tivozanib trial

Dec. 28, 2011

Intellikine patents new protein kinase inhibitors

Dec. 28, 2011

Clinical data reported on PR-104 in leukemia

Dec. 28, 2011

New exportin-1 inhibitors show preclinical potential in MCL and MM

Dec. 28, 2011

CytRx launches phase IIb study in advanced soft tissue sarcoma

Dec. 27, 2011

First patient with metastasized colorectal cancer treated in phase II trial of armed oncolytic virus

Dec. 27, 2011

Exelixis grants program license to Merck & Co.

Dec. 27, 2011

Novel farnesyl pyrophosphate synthase inhibitors discovered in Canada

Dec. 27, 2011

Merck & Co. patents new hPDK1 inhibitors

Dec. 27, 2011

Oral rigosertib shows promise as a therapy for myelodysplastic syndrome

Dec. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...